“Off-Label” Drug Marketing to be Reviewed During FDA Meeting
The FDA plans to hold a public meeting this summer on off-label marketing amid increasing pressure and lawsuits from industry to allow them to promote their drugs for unapproved uses.
The FDA plans to hold a public meeting this summer on off-label marketing amid increasing pressure and lawsuits from industry to allow them to promote their drugs for unapproved uses.